On Invalid Date, Benitec Biopharma (NASDAQ: BNTC) reported Q4 2023 earnings per share (EPS) of -$0.03, up 21.21% year over year. Total Benitec Biopharma earnings for the quarter were -$6.80 million. In the same quarter last year, Benitec Biopharma's earnings per share (EPS) was -$0.03.
As of Q2 2024, Benitec Biopharma's earnings has grown year over year. Benitec Biopharma's earnings in the past year totalled -$21.81 million.
What is BNTC's earnings date?
Benitec Biopharma's earnings date is Invalid Date. Add BNTC to your watchlist to be reminded of BNTC's next earnings announcement.
What was BNTC's revenue last quarter?
On Invalid Date, Benitec Biopharma (NASDAQ: BNTC) reported Q4 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Benitec Biopharma's revenue was $14.00 thousand.
What was BNTC's revenue growth in the past year?
As of Q2 2024, Benitec Biopharma's revenue has grown -1.61% year over year. This is 150.02 percentage points lower than the US Biotechnology industry revenue growth rate of 148.4%. Benitec Biopharma's revenue in the past year totalled $61.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.